Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS/AQ versus AL in Nigerian children with uncomplicated falciparum malaria
PACTR201508001188143Completed
- Sponsor
- Swiss Pharma
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in malaria and Falciparum malaria (PF) comparing Artesunate + amodiaquine (co-packaged), Artemisinin + amodiaquine (co-formulated) and Artemether + lumefantrine (3 arms). Primary endpoint: PCR-corrected cure rate. Started Aug 2009; status: completed.
02
Drugs
artesunateamodiaquineartemetherlumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on PACTR201508001188143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201508001188143.